Extract

The primary objective is to evaluate the safety and efficacy of eculizumab in transfusion dependent patients with hemolytic PNH.

Inclusion criteria

• Hemoglobinuria, Paroxysmal

Country

• Australia
• Belgium
• Canada
• France
• Germany
• Ireland
• Italy
• Netherlands
• Sweden
• Switzerland
• United Kingdom
• United States

Links

• nct
• ictrp